[1] JANSEN J,JANSEN K,NEVEN E,et al.Remote sensing and signaling in kidney proximal tubules stimulates gut microbiome-derived organic anion secretion[J].Proc Natl Acad Sci USA,2019,116(32):16105-16110.
[2] KIM Y H,KWAK K A,GIL H W,et al.Indoxyl sulfate promotes apoptosis in cultured osteoblast cells[J].BMC Pharmacol Toxicol,2013,14(1):60-69.
[3] MOZAR A,LOUVET L,GODIN C,et al.Indoxyl sulphate inhibits osteoclast differentiation and function[J].Nephrol Dial Transplant,2012,27(6):2176-2181.
[4] YAMAMOTO S.Fragility fractures in hemodialysis patients.Uremic toxins-related abnormal bone metabolism[J].Clin Calcium,2018,28(8):1093-1100.
[5] NII-KONO T,IWASAKI Y,UCHIDA M,et al.Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells[J].Kidney Int,2007,71(8):738-743.
[6] WATANABE K,TOMINARI T,HIRATA M,et al.Indoxyl sulfate,a uremic toxin in chronic kidney disease,suppresses both bone formation and bone resorption[J].Febs Open Bio,2017,7(8):1178-1185.
[7] KARBOWSKA M,SIEKLUCKA B,KAMINSKI T,et al.SAT-108 the effect of chronic exposure to indoxyl sulfate on geometric,densitometric,and morphometric parameters of bones in animal model[J].Kidney Int,2019,4(7):51-60.
[8] LEE K,KIM J,KIM E,et al.Water extract of Cnidii Rhizoma suppresses RANKL-induced osteoclastogenesis in RAW 264.7 cell by inhibiting NFATc1/c-Fos signaling and prevents ovariectomized bone loss in SD-rat[J].BMC Complement Altern Med,2019,19(1):207-219.
[9] NARUSE M,OTSUKA E,NARUSE M,et al.Inhibition of osteoclast formation by 3-methylcholanthrene,a ligand for aryl hydrocarbon receptor:suppression of osteoclast differentiation factor in osteogenic cells[J].Biochem Pharmacol,2004,67(1):119-127.
[10] KIM H Y,YOO T H,CHO J Y,et al.Indoxyl sulfate-induced TNF-α is regulated by crosstalk between the aryl hydrocarbon receptor,NF-κB,and SOCS2 in human macrophages[J].FASEB J,2019,33(10):10844-10858.
[11] WANG L,GAO Z,WANG L,et al.Upregulation of nuclear factor-κB activity mediates CYP24 expression and reactive oxygen species production in indoxyl sulfate-induced chronic kidney disease[J].Nephrology,2016,21(9):774-781.
[12] LIUA W C,WUCB C C B,LIMA P S,et al.Effect of uremic toxin -indoxyl sulfate on the skeletal system[J].Clinica Chimica Acta,2018,484(1):197-206.
[13] RONY S K,LIVSHITS G.Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin:the role of fibroblast growth factor 23[J].Biofactors,2014,40(6):555-568.
[14] 闫奇奇,郝丽,张森.FGF23与CKD患者钙磷代谢及心血管疾病关系研究进展[J].安徽医科大学学报,2019,54(1):158-162.
[15] LIN C J,PAN C F,CHUANG C K,et al.Association of indoxyl sulfate with fibroblast growth factor 23 in patients with advanced chronic kidney disease[J].Am J Med Sci,2014,347(5):370-376.
[16] 江杰,李仪,周红梅,等.血液透析患者血清FGF23水平的影响因素及其与矿物质骨代谢异常的关系研究[J/OL].中华肾病研究电子杂志,2018,7(3):111-115.
[17] BOVER J,JARA A,TRINIDAD P,et al.The calcemic response to PTH in the rat:effect of elevated PTH levels and uremia[J].Kidney Int,1994,46(2):310-317.
[18] LEVINE B S,RODRÍGUEZ M,FELSENFELD A J.Serum calcium and bone:effect of PTH,phosphate,vitamin D and uremia[J].Nefrologia,2014,34(5):658-669.
[19] EVENEPOEL P,BOVER J,TORRES P U.Parathyroid hormone metabolism and signaling in health and chronic kidney disease[J].Kidney Int,2016,90(6):1184-1190.
[20] DRVEKE,TILMAN B,MASSY Z A.Changing bone patterns with progression of chronic kidney disease[J].Kidney Int,2016,89(2):289-302.
[21] VERÓNICA A,MAGYAR C E,WANG B,et al.Ubiquitination-deubiquitination balance dictates ligand-stimulated PTHR sorting[J].J Bone Miner Res,2011,26(12):2923-2934.
[22] DIVIETI P,JOHN M R,JVPPNER H,et al.Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 pth/pthrp receptor[J].Endocrinology,2002,143(1):171-176.
[23] SPRAGUE S M,BELLORIN-FONT E,JORGETTI V,et al.Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis[J].Am J Kidney Dis,2015,67(4):559-566.
[24] WIECZOREK-SURDACKA E,HANFF E,CHYRCHEL B,et al.Distinct associations between plasma osteoprotegerin,homoarginine and asymmetric dimethylarginine in chronic kidney disease male patients with coronary artery disease[J].Amino Acids,2019,51(6):977-982.
[25] HRUSKA K.New concepts in renal osteodystrophy[J].Nephrol Dial Transplant,1998,13(11):2755-2760.
[26] HANG K,YE C,XU J,et al.Apelin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly through Wnt/β-catenin signaling pathway[J].Stem Cell Res Ther,2019,10(1):189-199.
[27] MOYSÉS R M A,SCHIAVI S C.Sclerostin,osteocytes,and chronic kidney disease-mineral bone disorder[J].Semin Dial,2015,28(6):578-586.
[28] DESJARDINS L,LIABEUF S,OLIVEIRA R B,et al.Uremic toxicity and sclerostin in chronic kidney disease patients[J].Nephrol Ther,2014,10(6):463-470.
[29] ARDAWI M S M,ROUZI A,AL-SIBIANI S A,et al.High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women:the center of excellence for osteoporosis research study[J].J Bone Miner Res,2012,27(12):2592-2602.
[30] 彭琼瑶,刘玲.骨硬化蛋白在慢性肾脏病血管钙化中的研究进展[J].临床肾脏病杂志,2019,19(3):218-222.
[31] SUNNY E,DANIEL S,TOM C,et al.Protein-bound uremic toxin profiling as a tool to optimize hemodialysis[J].PLoS One,2016,11(1):147-159.
[32] XIE T,BAO M C,ZHANG P,et al.Serum concentration of indoxyl sulfate in peritoneal dialysis patients and low-flux hemodialysis patients[J].Blood Purif,2019,48(2):183-190.
[33] YANG C Y,TARNG D C.Diet,gut microbiome and indoxyl sulphate in chronic kidney disease patients[J].Nephrology,2018,23(4):16-20.
[34] PATEL K P,LUO J G,PLUMMER N S,et al.The production of P-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores[J].Clin J Am Soc Nephrol,2012,7(6):982-988.
[35] TAKAYAMA F,TAKI K,NIWA T.Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis[J].Am J Kidney Dis,2003,41(3):142-145. |
